Advertisement

Indian

International

Aegon to sell its Central and Eastern European business to VIG

“This transaction will simplify Aegon’s footprint and strengthen our balance sheet.We are sharpening our strategic focus and are concentrating on those countries and business lines where Aegon can create most value. I would like to thank our employees in Hungary, Poland, Romania and Turkey for their significant contribution to Aegon over the years. We believe that our businesses will benefit greatly from the vast experience of VIG, a leading insurance group in the region””, said Lard Friese, CEO of Aegon. 

Moderna to ask US, European regulators to OK its vaccine for emergency use

Moderna created its shots with the U.S. National Institutes of Health and already had a hint they were working, but said it got the final needed results over the weekend that suggest the vaccine is more than 94% effective.
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. Across the Atlantic, British regulators also are assessing the Pfizer shot and another from AstraZeneca.

Briefs

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Advertisement

Articles

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Features

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Data

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Interviews

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Facts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.